| Structure of HCV NS3-4A Protease with an Inhibitor Derived from a Boronic Acid | |
Heteromer
| 1027-1696 | 1×ZN; 1×BE8; |
| Assess |
| HCV NS3-4A protease domain complexed with a macrocyclic ketoamide inhibitor, SCH419021 | |
Heteromer
| 1027-1696 | 1×ZN; 1×NHN; |
| Assess |
| Hepatitis C Protease NS3-4A serine protease with Ketoamide Inhibitor SCH225724 Bound | |
Heteromer
Q9QP61; | 1027-1207 | 2×ZN; 1×UNH; |
| Assess |
| CRYSTAL STRUCTURE OF HCV NS3 PROTEASE DOMAIN: NS4A PEPTIDE COMPLEX WITH COVALENTLY BOUND PYRROLIDIN… | |
Heteromer
O39914; | 1027-1206 | 2×ZN; 1×CPX; |
| Assess |
| Crystal structure of the designed protein DNCR2/danoprevir/NS3a complex | |
Heteromer
| 1030-1208 | 1×ZN; 1×TSV; 3×SO4; |
| Assess |
| HCV NS3 Protease Domain with ketoamide inhibitor | |
Heteromer
Q9WMX2; | 1055-1205 | 1×ZN; |
| Assess |
| Crystal structure of NS3/4A protease variant R155K in complex with vaniprevir | | monomer | 1017-1687 | 1×SU3; 2×SO4; 1×ZN; |
| Assess |
| HCV NS3/4A protease domain of genotype 1a3a chimera in complex with glecaprevir | | monomer | 1013-1207 | 2×EDO; 1×ZN; 2×SO4; 1×O31; 1×CL; |
| Assess |
| HCV NS3/4A protease A156T, D168E double mutant in complex with glecaprevir | | monomer | 1013-1207 | 1×ZN; 1×O31; 1×GOL; 3×SO4; |
| Assess |
| HCV NS3/4A protease domain of genotype 1a D168E in complex with glecaprevir | | monomer | 1013-1207 | 1×ZN; 1×O31; 2×SO4; 1×CL; |
| Assess |
| Crystal structure of HCV NS3/4A protease in complex with JZ01-15, an analogue of 5172-mcP1P3 | | monomer | 1013-1206 | 1×9H4; 1×SO4; 1×ZN; |
| Assess |
| Crystal structure of HCV NS3/4A protease in complex with AM-07, an analogue of 5172-mcP1P3 | | monomer | 1013-1206 | 1×9H7; 1×SO4; 1×ZN; |
| Assess |
| HCV NS3/4A protease A156T mutant | | monomer | 1013-1206 | 1×ZN; 1×GOL; 4×SO4; |
| Assess |
| HCV NS3/4A protease domain of genotype 1a C159 in complex with glecaprevir | | monomer | 1013-1206 | 1×O31; 1×ZN; 2×SO4; 1×CL; |
| Assess |
| HCV NS3/4A protease domain of genotype 1a in complex with glecaprevir | | monomer | 1013-1205 | 4×EDO; 2×SO4; 1×ZN; 1×O31; |
| Assess |
| HCV NS3/4A protease A156T mutant in complex with glecaprevir | | monomer | 1013-1205 | 1×ZN; 1×O31; 2×GOL; 2×SO4; |
| Assess |
| HCV NS3/4A protease domain of genotype 1a3a chimera in complex with grazoprevir | | monomer | 1013-1205 | 1×SUE; 1×ZN; 2×MES; 3×SO4; |
| Assess |
| HCV NS3/4A protease A156T, D168E double mutant | | monomer | 1030-1207 | 1×ZN; 1×BME; 3×SO4; |
| Assess |
| Crystal structure of HCV NS3/4A D168A protease in complex with JZ01-15 | | monomer | 1030-1205 | 1×9H4; 1×ZN; 4×EDO; 2×GOL; 2×SO4; |
| Assess |
| Crystal structure of HCV NS3/4A protease in complex with NR01-145 | | monomer | 1030-1205 | 1×ZN; 1×ZKJ; 3×EDO; 1×SO4; |
| Assess |
| Crystal structure of HCV NS3/4A D168A protease in complex with NR01-145 | | monomer | 1030-1205 | 1×ZKJ; 1×ZN; 1×SO4; |
| Assess |
| Crystal structure of HCV NS3/4A protease in complex with NR01-127 | | monomer | 1030-1205 | 1×ZN; 1×ZJG; 9×EDO; 1×SO4; |
| Assess |
| Crystal structure of HCV NS3/4A protease in complex with NR01-115 | | monomer | 1030-1205 | 1×ZN; 11×EDO; 1×ZKA; 1×SO4; |
| Assess |
| Crystal structure of HCV NS3/4A D168A protease in complex with NR01-149 | | monomer | 1030-1205 | 1×ZN; 1×ZJJ; 11×EDO; 1×SO4; |
| Assess |
| Crystal structure of HCV NS3/4A D168A protease in complex with JZ01-19 | | monomer | 1030-1205 | 5×EDO; 1×ZN; 1×ZJP; 1×SO4; |
| Assess |
| Crystal structure of HCV NS3/4A D168A protease in complex with NR01-127 | | monomer | 1030-1205 | 1×ZJG; 4×EDO; 1×ZN; 3×SO4; |
| Assess |
| Crystal structure of HCV NS3/4A protease in complex with NR01-149 | | monomer | 1030-1205 | 1×ZN; 1×ZJJ; 1×EDO; 1×SO4; |
| Assess |
| Crystal structure of HCV NS3/4A D168A protease in complex with NR01-115 | | monomer | 1030-1203 | 1×ZN; 1×ZKA; 10×EDO; 2×SO4; |
| Assess |